Health Care

When it comes to paying for health care, consumers have more skin in the game than they did in the past.

Federal law supports you if you want to keep treatments or medicine secret.

Drug giant Baxter International inked a licensing partnership with smaller rival Cell Therapeutics to develop and commercialize a drug to help treat myelofibrosis and leukemia.

Eli Lilly will invest more than $700 million to boost its insulin manufacturing capacity in Puerto Rico, France, China and the United States.

Some consumers might be facing higher health-insurance costs. Here's why. 

According to a new survey, 90% of employees admit they have come into the office despite knowing they are sick—an increase of 10% from last year. Here are three signs you are better off staying home.

Teva Pharmaceutical’s chief executive Jeremy Levin abruptly stepped down from his role at the Israeli drug maker on Wednesday.

Pfizer reported better-than-expected third-quarter earnings helped by cost cuts and growing sales of recently approved cancer medicines.

New intelligent bionics and exoskeletons are expected to one day help patients who haven’t used their lower bodies in years.

When old medical debt is keeping you from moving ahead with your life, it's time to take action. 

Hundreds of thousands of children die from Malaria each year, but new research could help catch deadly diseases before they reach maturity.

The medical device maker reported improved earnings in the third quarter despite lagging sales of pacemakers and backed its full-year outlook.

To save as much as $2 billion a year, Teva Pharmaceutical said Thursday it was expanding its cost-cutting program by axing 10% of its workforce.

The moves are aimed at slimming down the global drug giant and narrowing its focus.

Oncolytics reported that its experimental lung cancer drug shrunk tumors in 92% of patients in a study.

Oncolytics reported that its experimental lung cancer drug shrunk tumors in 92% of patients in a study.

Isis Pharmaceuticals has once again joined forces with Biogen Idec to advance the treatment for neurological disorders.

Amgen said over the weekend it would  buy cancer drug maker Onyx Pharmaceuticals  for about $10.4 billion in one of the biggest-ever biotech deals.

St. Jude Medical agreed to buy Endosense for up to $230 million, providing it with catheter technologies that can be used during heart surgeries.

While health-related devices have yet to cause any catastrophes, the FDA and CIS are being proactive in trying to stop an attack before it happens.